Alkermes plc. Gain (Loss) on Disposition of Property Plant Equipment
Alkermes plc. (ALKS) reported Gain (Loss) on Disposition of Property Plant Equipment of $3.27 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-02-16.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfPropertyPlantEquipment · last filed 2018-02-16
- Alkermes plc. gain (loss) on disposition of property plant equipment for the quarter ending 2015-12-31 was $2.69M, a 90.46% decline year-over-year.
- Alkermes plc. gain (loss) on disposition of property plant equipment for the quarter ending 2015-09-30 was $482.00K.
- Alkermes plc. gain (loss) on disposition of property plant equipment for the quarter ending 2014-12-31 was $28.16M.
- Alkermes plc. gain (loss) on disposition of property plant equipment for the quarter ending 2014-09-30 was -$218.00K.
- Alkermes plc. gain (loss) on disposition of property plant equipment for fiscal 2015 was $3.27M, a 91.84% decline from fiscal 2014.
- Alkermes plc. gain (loss) on disposition of property plant equipment for fiscal 2014 was $40.10M.
- Alkermes plc. gain (loss) on disposition of property plant equipment for fiscal 2013 was -$373.00K.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment 3 month | Gain (Loss) on Disposition of Property Plant Equipment 6 month | Gain (Loss) on Disposition of Property Plant Equipment 9 month | Gain (Loss) on Disposition of Property Plant Equipment 12 month |
|---|---|---|---|---|
| 2015-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $3.17M derived: sum of 2 quarters · filed 2018-02-16 | $3.27M 10-K · filed 2018-02-16 | |
| 2015-09-30 | $482.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $586.00K 10-Q · filed 2015-10-29 | ||
| 2015-06-30 | $104.00K 10-Q · filed 2015-07-30 | |||
| 2014-12-31 | $28.16M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $27.94M derived: sum of 2 quarters · filed 2017-02-17 | $40.10M 10-K · filed 2017-02-17 | |
| 2014-09-30 | -$218.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $11.94M 10-Q · filed 2015-10-29 | ||
| 2014-06-30 | $12.16M 10-Q · filed 2015-07-30 | |||
| 2013-12-31 | -$129.00K 10-K · filed 2016-02-25 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | -$391.00K 10-Q · filed 2014-10-29 | ||
| 2013-06-30 | -$391.00K 10-Q · filed 2014-07-31 | |||
| 2013-03-31 | -$373.00K 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |